DexCom, Inc. (DXCM)
Last updated: 2026-10-20 20:53:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
DexCom, Inc. (DXCM) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $85.74, with a market capitalization of $32.47B and a P/E ratio of 32.46. Over the past 52 weeks, its price has ranged from $54.11 to $92.59. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$32.47B | |
$86.11 | |
$164.86 | |
$0.34 | |
$85.98 | |
1.67M | |
4.35M | |
32.46 | |
$92.59 | |
$54.11 | |
-- | |
2001-12-30 |
DexCom, Inc. (DXCM) After-Hours Stock Price
DexCom, Inc. (DXCM) is trading at $85.84 in after-hours trading as of 2026-10-20 20:35:00, down 0.17% ($0.15) from the regular-session close of $85.98.
After-hours trading shows how investors are pricing DXCM after the regular session closes. The current after-hours price is near the regular-session close, indicating cautious after-hours sentiment.
DexCom, Inc. (DXCM) 7-Day Stock Price Change
Over the past seven days, DexCom, Inc. (DXCM) moved from $84.11 to $85.74, representing a gain of 1.93% ($1.63).
The stock traded between $82.94 and $88.87 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 3.52 million shares, up versus the previous seven-day period, indicating higher trading activity.
DXCM 52-Week Price Position
Position in Range: 82.2%
DXCM is currently trading at $85.74, placing it 82.2% of the way from its 52-week low of $54.11 to its 52-week high of $92.59. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is DexCom, Inc. (DXCM)?
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
DexCom, Inc. Information
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 11100 |
| CEO | Jacob Steven Leach |
| Founded | 1999 |
| Exchange | NASDAQ |
| Company Website |
How to Buy DexCom, Inc. (DXCM) Stock on MEXC
Eligible investors can buy real shares of DexCom, Inc. (DXCM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is DexCom, Inc. (DXCM) stock price today?
2.Is DXCM stock going up or down today?
3.What is DXCM pre-market price?
4.What is DXCM after-hours price?
5.Is DXCM stock trading now?
6.Where does DXCM sit relative to its 52-week high and low?
7.What sector is DexCom, Inc. in?
8.What is DexCom, Inc.'s market capitalization and where is it listed?
9.How is DXCM valued in terms of P/E ratio and EPS?
10.Does DexCom, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
DXCM Stock Calculator
Estimate the value between DXCM shares and USD.
DXCM Shares to USD
1.00 DXCM shares = 85.736 USD
Calculations are estimates based on the latest available price and are for reference only.


